Back

De-escalation/discontinuation of oxygen-therapy and medication is feasible and safe in chronic thromboembolic pulmonary hypertension patients treated with balloon pulmonary angioplasty

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Advances in Chronic Thromboembolic Pulmonary Hypertension Pulmonary Hypertension ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Mai Kimura

Keio University Hospital, Tokyo (Japan)

2 More presentations in this session

Presentation thumbnail
Accurate and efficient non-invasive strategy for early identification of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism (InShape II study)
Doctor E. Klok (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Favourable safety profile of S62798, a potent TAFIa (activated thrombin-activatable fibrinolysis inhibitor) inhibitor, in first-in-man study in healthy subjects
Mrs F. Petit Dop (Suresnes, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in Chronic Thromboembolic Pulmonary Hypertension

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources